Periodized Aerobic Interval Training in Metabolic Syndrome

Not Applicable

Completed

• Conditions: Metabolic Syndrome X; Metabolic Syndrome

• Registration Number: NCT03119493
• Lead Sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho

Brief Summary

Autonomic disfunction present in metabolic syndrome subjects is related by a greater vulnerability of the heart and risk of cardiovascular events. In this context, aerobic interval training has been highlighted by its easy applicability and benefits effects in autonomic modulation in different populations. Therefore the studies that use de aerobic interval training in this different populations didn't realize a periodization of training with preparatory periods with progressive increase of load, specific phases with less duration predominating the intensity and transition periods for recuperation. Additionally, there isn't studies that investigate the effects of aerobic interval training in autonomic modulation of individuals with metabolic syndrome. In this context, periodized aerobic interval training can arise like a new type of treatment that offering security and efficacy in subjects with metabolic syndrome. So, the aim of the study is evaluate the effect of periodized aerobic interval training in cardiac autonomic modulation and cardiovascular and anthropometric parameters of individuals with metabolic syndrome.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-06-01
• Primary Completion: 2016-12-01
• Study Completion: 2016-12-01
• Status Verified: 2017-04
• Study First Submitted: 2017-04-07
• Study First Submitted QC: 2017-04-13
• Last Update Submitted: 2017-04-13
• Study First Posted: 2017-04-18
• Last Update Posted: 2017-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

• Metabolic syndrome according to international diabetes federation (IDF) definition
• Aged between 40 to 60 years

Exclusion Criteria

• Participants who are currently participating in any regular exercise programs last six months;
• Use of drugs or medication (Except for risk factors of metabolic syndrome control);
• Inflammatory or infectious process;
• Musculotendinous or osteoarticular injuries in the lower limbs and/or spine;
• Chronic pulmonary disease;
• Neurological disorders;
• Cardiovascular disease.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Heart rate variability	16 week after allocation

Secondary Outcome Measures

Name	Time	Method
Cardiovascular parameter : heart rate	16 week after allocation
Cardiovascular parameter: blood pressure	16 week after allocation
Anthropometric parameter: hit waist ratio	16 week after allocation
Anthropometric parameter: body mass index	16 week after allocation	Measured by weight and height
Anthropometric parameter: abdominal circumference	16 week after allocation

Trial Locations

Locations (1)

Laís Manata Vanzella; 🇧🇷 Presidente Prudente, São Paulo, Brazil